In 2016, CR Pharmaceutical realized ￥8,981 million of operating revenue with a year-on-year growth of 13.69%; whereas the net profit decreased by 4.11% on year-on-year basis, realizing ￥1,197 million. Among which, the operating revenue of the self-diagnosis field relying mainly on OTC and business relevant to comprehensive health reached ￥4,689 million with a year-on-year growth of 7.06%. One of the key measures that the company plans to take in 2017 is to make vigorous efforts in the comprehensive health industry, including developing the healthy products extended on the basis of the core therapy area such as ginger tea with brown sugar, peppermint candy, etc., the mainstream dietary nutritious supplements in the healthcare product market such as vitamins and minerals, etc., as well as tonic herbal medicine and the herbal medicine can be taken as both a food and medicine etc. based on traditional medicinal materials.